While our previous study did not observe hyperglycemia in control animals (Nomura et al., 2023), hyperglycemia has often been observed in nondiabetic SCI patients (Kobayakawa et al., 2014), and GLP-1 receptor agonists may improve motor function by controlling hyperglycemia after SCI. This evidence concerns the gene GLP1R and Hyperglycemia.